CIBC World Markets’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $21.6M | Buy |
+47,710
| New | +$20.6M | 0.1% | 136 |
|
|
2025
Q2 | $22.5M | Buy |
50,606
+19,599
| +63% | +$9.03M | 0.14% | 124 |
|
|
2025
Q1 | $15M | Sell |
31,007
-15,332
| -33% | -$7.14M | 0.12% | 129 |
|
|
2024
Q4 | $18.7M | Buy |
46,339
+5,665
| +14% | +$2.63M | 0.11% | 142 |
|
|
2024
Q3 | $18.9M | Sell |
40,674
-11,254
| -22% | -$5.41M | 0.14% | 120 |
|
|
2024
Q2 | $24.3M | Buy |
51,928
+9,069
| +21% | +$3.94M | 0.16% | 97 |
|
|
2024
Q1 | $17.9M | Sell |
42,859
-48,560
| -53% | -$20.5M | 0.12% | 129 |
|
|
2023
Q4 | $37.2M | Buy |
91,419
+47,483
| +108% | +$17.5M | 0.2% | 79 |
|
|
2023
Q3 | $15.3M | Sell |
43,936
-7,821
| -15% | -$2.74M | 0.15% | 109 |
|
|
2023
Q2 | $18.2M | Buy |
51,757
+35,671
| +222% | +$12M | 0.15% | 115 |
|
|
2023
Q1 | $5.07M | Sell |
16,086
-17,144
| -52% | -$5.14M | 0.08% | 197 |
|
|
2022
Q4 | $9.6M | Buy |
33,230
+29,339
| +754% | +$8.94M | 0.06% | 204 |
|
|
2022
Q3 | $1.13M | Sell |
3,891
-28,220
| -88% | -$8.12M | 0.02% | 344 |
|
|
2022
Q2 | $9.05M | Sell |
32,111
-27,629
| -46% | -$7.4M | 0.09% | 146 |
|
|
2022
Q1 | $15.6M | Buy |
+59,740
| New | +$14.2M | 0.12% | 126 |
|
|
2021
Q4 | – | Sell |
-68,765
| Closed | -$12.5M | – | 636 |
|
|
2021
Q3 | $12.5M | Buy |
68,765
+47,986
| +231% | +$9.37M | 0.08% | 169 |
|
|
2021
Q2 | $4.19M | Sell |
20,779
-110,750
| -84% | -$23.2M | 0.03% | 290 |
|
|
2021
Q1 | $28.3M | Buy |
131,529
+60,367
| +85% | +$13.3M | 0.18% | 103 |
|
|
2020
Q4 | $16.8M | Buy |
71,162
+25,297
| +55% | +$5.8M | 0.08% | 167 |
|
|
2020
Q3 | $12.5M | Buy |
45,865
+3,648
| +9% | +$1.01M | 0.12% | 169 |
|
|
2020
Q2 | $12.3M | Sell |
42,217
-30,555
| -42% | -$8.28M | 0.13% | 148 |
|
|
2020
Q1 | $17.3M | Buy |
72,772
+21,379
| +42% | +$4.9M | 0.22% | 105 |
|
|
2019
Q4 | $11.3M | Sell |
51,393
-50,204
| -49% | -$10.2M | 0.07% | 243 |
|
|
2019
Q3 | $17.2M | Buy |
101,597
+43,073
| +74% | +$7.62M | 0.16% | 150 |
|
|
2019
Q2 | $10.7M | Sell |
58,524
-2,674
| -4% | -$467K | 0.08% | 258 |
|
|
2019
Q1 | $11.3M | Sell |
61,198
-89,538
| -59% | -$16.5M | 0.09% | 200 |
|
|
2018
Q4 | $25M | Buy |
150,736
+73,901
| +96% | +$12.8M | 0.23% | 115 |
|
|
2018
Q3 | $14.8M | Buy |
76,835
+20,202
| +36% | +$3.6M | 0.13% | 169 |
|
|
2018
Q2 | $9.63M | Buy |
56,633
+9,571
| +20% | +$1.48M | 0.08% | 243 |
|
|
2018
Q1 | $7.67M | Sell |
47,062
-28,065
| -37% | -$4.58M | 0.08% | 223 |
|
|
2017
Q4 | $11.3M | Buy |
75,127
+17,596
| +31% | +$2.61M | 0.08% | 200 |
|
|
2017
Q3 | $8.75M | Buy |
57,531
+3,783
| +7% | +$569K | 0.08% | 194 |
|
|
2017
Q2 | $6.93M | Buy |
53,748
+27,816
| +107% | +$3.35M | 0.07% | 246 |
|
|
2017
Q1 | $2.84M | Buy |
25,932
+8,885
| +52% | +$782K | 0.02% | 319 |
|
|
2016
Q4 | $1.26M | Buy |
17,047
+11,984
| +237% | +$975K | 0.01% | 370 |
|
|
2016
Q3 | $442K | Sell |
5,063
-11,602
| -70% | -$1.1M | 0.01% | 230 |
|
|
2016
Q2 | $1.43M | Buy |
16,665
+1,573
| +10% | +$136K | 0.04% | 146 |
|
|
2016
Q1 | $1.2M | Sell |
15,092
-5,598
| -27% | -$506K | 0.03% | 163 |
|
|
2015
Q4 | $2.6M | Buy |
20,690
+3,760
| +22% | +$454K | 0.05% | 155 |
|
|
2015
Q3 | $1.76M | Buy |
16,930
+9,926
| +142% | +$1.28M | 0.05% | 162 |
|
|
2015
Q2 | $865K | Buy |
+7,004
| New | +$883K | 0.03% | 130 |
|
Other funds holding VRTX
CIBC World Markets's VRTX Position: Q4 2025 in Review
CIBC World Markets opened a new position in Vertex Pharmaceuticals (VRTX) in Q4 2025: 47,710 shares worth $21.6M. The stake represents 0.1% of the portfolio and ranks #136 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in VRTX as recently as Q2 2025.
CIBC World Markets first reported a position in VRTX in Q2 2015 and has held it in 41 quarters since. The position peaked at $37.2M in Q4 2023. 1,668 funds tracked by Wall St. Rank hold VRTX as of Q4 2025.
- CIBC World Markets held 47,710 shares of Vertex Pharmaceuticals worth $21.6M as of Q4 2025.
- Vertex Pharmaceuticals was a new CIBC World Markets position in Q4 2025.
- Vertex Pharmaceuticals made up 0.1% of CIBC World Markets's portfolio in Q4 2025, its #136 holding.
- CIBC World Markets first reported a position in Vertex Pharmaceuticals in Q2 2015 and has held it in 41 quarters since.
- CIBC World Markets's Vertex Pharmaceuticals position peaked at $37.2M in Q4 2023.
- 1,668 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2025.
Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.